Merck

Merck’s China Agent Gets Approval to Start Selling Rotavirus Diarrhea Vaccine

Merck’s China Agent Gets Approval to Start Selling Rotavirus Diarrhea Vaccine

Chongqing Zhifei Biological Products Co., which acts as a sales agent exclusively to American pharmaceutical giant Merck & Co. Inc.,…

Apr 16, 2018
Dou Shicong
Merck Director Welcomes China’s Efforts to Open Up Economy

Merck Director Welcomes China’s Efforts to Open Up Economy

Merck Director Welcomes China’s Efforts to Open Up Economy

Apr 12, 2018
Feng Yunqing
Lepu Medical Votes for Merck's Acquisition of Australian Biotech Company

Lepu Medical Votes for Merck's Acquisition of Australian Biotech Company

Lepu Medical Technology (Beijing) Co. has resolved in favor of U.S. medical giant Merck & Co.’s acquisition of all shares…

Feb 23, 2018
Tang Shihua
Merck’s HPV Vaccine Prepares for Bidding in China; Vaccination Will Be Available by Year-End

Merck’s HPV Vaccine Prepares for Bidding in China; Vaccination Will Be Available by Year-End

US-based pharmaceutical giant Merck & Co., Inc. [NYSE:MRK] has started bidding for its cervical cancer vaccine, Gardasil. Vaccinations will be available for the women in China by the end of this year.

Nov 10, 2017
Dou Shicong
Pharmaceutical Multinationals Ramp Up Investment in China

Pharmaceutical Multinationals Ramp Up Investment in China

Multinational pharmaceutical firms are upping their investment in China to bring the industry’s latest technology to the world’s second largest…

May 22, 2017
Qian Tongxin